Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.27176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Michael S Schechter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cystic Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Background
The benefit of antibiotic treatment of acute drops in FEV 1 percent predicted (FEV 1 pp) has been clearly established, but data from the early 2000s showed inconsistent treatment. Further, there is no empirical evidence for what magnitude of drop is clinically significant.
Methods
We used data from the CF Foundation Patient Registry (CFFPR) from 2016 to 2019 to determine the association between treatment (any IV antibiotics, only oral or newly prescribed inhaled antibiotics, or no antibiotic therapy) following a decline of ≥5% from baseline FEV 1 pp and return to 100% baseline FEV 1 pp days using multivariable logistic regression including an interaction between the magnitude of decline and treatment category.
Results
Overall, 16,495 PWCF had a decline: 16.5% were treated with IV antibiotics, 25.0% non‐IV antibiotics, and 58.5% received no antibiotics. Antibiotic treatment was more likely for those with lower lung function, history of a positive PA culture, older age and larger FEV 1 decline ( p < 0.001). Treatment with IV antibiotics or oral/inhaled antibiotics was associated with a higher odds of recovery to baseline compared to no treatment across all levels of decline, including declines of 5%–10%.
Conclusions
A large proportion of acute drops in FEV1 pp continue to be untreated, especially in younger patients and those with higher baseline lung function. Acute drops as small as 5% predicted are less likely to be recovered if antibiotic treatment is not prescribed. These findings suggest the need for more aggressive antimicrobial treatment of acute drops in FEV 1 , including those of a magnitude previously believed to be associated with self‐recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, USA.
- Cystic Fibrosis Foundation, Bethesda, Maryland, USA.
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- National Organization for Rare Disorders, Washington, District of Columbia, USA.
- Indiana University., Indianapolis, Indiana, USA.
- University of Arizona, Tucson, Arizona, USA.
ORCID-Profile: Michael S Schechter, Elizabeth A Cromwell, Clement L Ren, D B Sanders, Wayne J Morgan
Förderung
- Cystic Fibrosis Foundation
Zitieren
APA
Schechter, M. S., Ostrenga, J. S., Cromwell, E. A., Ren, C. L., Fink, A. K., Sanders, D. B., & Morgan, W. J. (2024). Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27176
Vancouver
Schechter MS, Ostrenga JS, Cromwell EA, Ren CL, Fink AK, Sanders DB, et al. Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27176
BibTeX
@article{Schechter2024,
author = {Schechter, Michael S and Ostrenga, Joshua S and Cromwell, Elizabeth A and Ren, Clement L and Fink, Aliza K and Sanders, D B and Morgan, Wayne J},
title = {Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.27176}
}
EUVIMED